July 29, 2025

Postpartum Pelvic Floor Disorders Often Overlooked, Review Finds

Emerging diagnostic tools such as dynamic ultrasound and anorectal manometry offer clinicians improved evaluation of postpartum pelvic floor disorders, yet standardized screening protocols remain limited.

Conexiant

July 29, 2025

When Lightning Strikes

What ophthalmologists need to know about ocular manifestations of electrical trauma

The Ophthalmologist

July 29, 2025

Elevating Sarcoma Care: Multidisciplinary Collaboration and Innovation in Rare Cancer Treatment Page Summary

Sarcomas remain one of the most diverse and challenging cancer types to diagnose and treat. Baptist Health Cancer Care continues to advance care through coordinated expertise, early detection efforts, and emerging research opportunities.

Baptist Health South Florida

July 28, 2025

The Art of Eyes 2025

Showcasing artwork and images from across the spectrum of ophthalmology

The Ophthalmologist

July 25, 2025

Rare Pediatric Knee Fractures Reviewed in Depth

Pediatric tibial tubercle fractures continue to present diagnostic and treatment challenges as clinicians navigate variable imaging use, classification systems, and surgical thresholds in the absence of standardized guidelines.

Conexiant

July 23, 2025

Philadelphia Magazine Names 142 Fox Chase Cancer Center Physicians ‘Top Doctors’

One hundred and forty-two Fox Chase Cancer Center physicians have been named to Philadelphia magazine’s “Top Doctors” list for 2025. Physicians on the list were nominated by a national survey of their professional peers.

Fox Chase Cancer Center

July 23, 2025

Fox Chase Takes Center Stage at 2025 National Meetings

Fox Chase surgical fellows and faculty pave the way for better cancer outcomes with research presented at SSO, ASCO, AUA, and SSO.

Fox Chase Cancer Center

July 23, 2025

FDA Grants Breakthrough Status to Melanoma Test

The FDA has granted Breakthrough Device designation to Castle Biosciences’ DecisionDx-Melanoma test, a gene expression profile assay designed to improve risk stratification and personalized care in cutaneous melanoma.

Conexiant

July 23, 2025

Soaring to New Heights: Fox Chase Leadership, Faculty, Residents, and Fellows

A hallmark of Fox Chase leadership, fellows, residents and faculty is their ability to persevere—to keep climbing the often-difficult ascent of cancer discovery and delivery—no matter what. Meet some of the exceptional researchers, scientists, and clinicians determined to make decisive inroads in cancer care.

Fox Chase Cancer Center